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Abstract Hepatocytes undergo marked changes in proliferation
during normal liver development. In order to elucidate the
mechanism for these changes, we examined the ontogeny of
expression for the known cyclin-dependent kinase inhibitors
(CKIs), p15Ink4b, p16Ink4a, p18Ink4c, p19Ink4d, p21Cip1, p27Kip1 and
p57Kip2. All except p16Ink4a were expressed at some time between
late gestation and adulthood. The mRNA and protein expression
patterns for p15Ink4b and p57Kip2 were consistent with a role for
these CKIs in the regulation of hepatocyte proliferation.
Specifically, p57Kip2 may contribute to hepatocyte growth arrest
that occurs in term fetuses, while p15Ink4b may contribute to the
maintenance of adult hepatocytes in a quiescent state. These
results assign a possible role to two CKIs not previously
identified as involved in hepatocyte cell cycle control. ß 2000
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Over the last 3 days before birth in the rat, the liver triples
in size. This remarkable growth is characterized by a surge in
fetal hepatocyte proliferation. Rat hepatocytes then undergo a
period of temporary growth arrest at the time of parturition
[1,2], following which they synchronously re-enter the cell
cycle. They then make a gradual transition beyond the ¢rst
postnatal week to the quiescent state associated with the adult
rat hepatocyte phenotype. Both the peripartum growth arrest
and the transition to a quiescent adult phenotype are associ-
ated with accumulation of hepatocytes in the G1 phase of the
cell cycle and a decline in cyclin D-associated cyclin-depen-
dent kinase (CDK) activity [3].
Candidates for mediating this decline in perinatal CDK
activity include the CDK inhibitors (CKIs), a group of small
proteins that regulate cell cycle progression throughout its
various stages [4,5]. There are two families of CKIs based
on their structures and the particular CDKs they interact
with. The Cip/Kip family, p21Cip1, p27Kip1 and p57Kip2, can
bind to complexes containing all known CDKs. They there-
fore have the potential to block progression through all
phases of the cell cycle. The Ink4 family, p15Ink4b, p16Ink4a,
p18Ink4c and p19Ink4d, bind only CDK4 and CDK6, thereby
mediating G1 cell cycle arrest. Whether the individual mem-
bers of the Ink4 and Cip/Kip families have overlapping versus
non-redundant roles is not entirely clear.
We have examined the role of individual CKIs in the con-
trol of hepatocyte proliferation by examining their expression
during the perinatal transition, the postnatal transition to a
quiescent adult hepatocyte phenotype, and the period of hep-
atocyte growth stimulation induced by partial hepatectomy.
Our results indicate a possible role for two CKIs, p15Ink4b and
p57Kip2, that have previously not been recognized as regula-
tors of the hepatocyte cell cycle.
2. Materials and methods
2.1. Animals
Timed pregnant Sprague^Dawley rats (Charles River Breeding Lab-
oratory, Wilmington, MA, USA; day of conception designated as
embryonic day 0 [E0]; term as E21) were used for all fetal studies.
Samples were obtained by Cesarean section performed under pento-
barbital anesthesia (50 mg/kg, given by intraperitoneal injection).
Postnatal studies used o¡spring of timed pregnant dams that were
allowed to deliver spontaneously and nurse their pups. Adult liver
samples were from male Sprague^Dawley rats weighing 200^250 g.
Partial (two-thirds) hepatectomy was performed on 125^150 g male
Sprague^Dawley rats under methoxy£uorane anesthesia. For these
studies, control animals underwent sham hepatectomy.
2.2. Analysis of CKI RNA and protein content
For reverse transcriptase-polymerase chain reaction (RT-PCR), iso-
lation of total RNA from frozen liver samples was performed as
described previously [6]. cDNA was generated using 3 Wg of total
RNA in the Superscript1 Preampli¢cation System (Life Technologies,
Gaithersburg, MD, USA). Rat-derived sequence data were used for
primer design except when not available (p21Cip1, p57Kip2, p18Ink4c,
p19Ink4d). In these cases, primers were designed to target the areas
of greatest homology between mouse and human sequences.
PCR primers were designed using the MIT Primer3 design program
(http://www.genome.wi.mit.edu//cgi-bin/primer/primer3.cgi). The prim-
er sequences used, PCR conditions and expected product sizes are
shown in Table 1. RT-PCR was performed in a semi-quantitative
fashion using the ‘primer-dropping’ method with L-actin as the con-
trol RNA [3]. PCR products were sequenced (Yale University Keck
Biotechnology DNA Sequencing Laboratories, New Haven, CT,
USA) to con¢rm the speci¢city of the PCR primers.
For Northern blots, total RNA (10 Wg) was separated on a 1%
formaldehyde-agarose gel, followed by transfer to nitrocellulose mem-
branes (Amersham, Piscataway, NJ, USA). Filters were probed with
either radiolabeled cDNA probes (human p15Ink4b, mouse p16Ink4a) or
riboprobes prepared using CKI PCR products. cDNA probes were
labeled with 5P[K-32P]CTP to a speci¢c activity of 2.0U108 cpm/Wg.
Following hybridization, membranes were analyzed by phosphor-
imaging.
Western immunoblotting was performed as described previously [7].
Primary antibodies were obtained from Santa Cruz Biotechnology
(Santa Cruz, CA, USA). Anti-p57Kip2 was a rabbit polyclonal IgG
directed at an internal region of human p57Kip2. Several p15Ink4b anti-
bodies were used, including a rabbit polyclonal IgG directed at the
amino terminus of human p15Ink4b, a goat polyclonal IgG directed at
the carboxy terminus of mouse p15Ink4b, and a goat polyclonal IgG
directed at the amino terminus of human p15Ink4b. In all cases, detec-
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tion employed an enhanced chemiluminescent system (ECL; Amer-
sham, Arlington Heights, IL, USA).
2.3. Immunohistochemistry
Formalin-¢xed, para⁄n-embedded samples of livers were sectioned
(5 Wm), depara⁄nized, rehydrated and stained for p15Ink4b or p57Kip2.
Primary antibodies were goat polyclonal IgG directed at the amino
terminus of human p15Ink4b and at the amino terminus of mouse
p57Kip2 (both obtained from Santa Cruz Biotechnology). Secondary
antibodies and detection methods were the same as those employed
previously [2]. In both cases, the speci¢city of our results was con-
¢rmed by the ability of the respective peptide immunogens to block
staining.
3. Results and discussion
To establish the presence or absence of the CKIs in rat
liver, RT-PCR for all CKIs was initially performed under
non-quantitative conditions using total RNA from several de-
velopmental time points. For all of the CKIs except p16Ink4a,
a speci¢c PCR product could be detected for at least one of
the time points tested (not shown). No PCR product could be
detected for p16Ink4a in rat liver samples from any develop-
mental time point. Multiple primer sets were used for these
experiments. One primer set in particular (Table 1), aimed at
exon 1, detected the expected 160 bp product using RNA
from the D9 mouse mesothelioma cell line. This product
was not detected in cDNA preparations from fetal, newborn
or adult liver, nor was it detected using cDNA from regener-
ating liver or cultured fetal or adult rat hepatocytes. However,
it was present when ampli¢ed from rat placenta cDNA (not
shown). Based on these results, we concluded that p16Ink4a is
not expressed in normal rat liver during the developmental
period.
We proceeded to examine the ontogeny of the six expressed
CKIs using semi-quantitative RT-PCR (Fig. 1). Of the Ink4
CKIs, p15Ink4b was overexpressed in adult liver while p18Ink4c
was expressed at relatively constant levels at all time points.
p19Ink4d was expressed in fetal liver but was barely detectable
in adult liver. Examination of Cip/Kip expression also indi-
cated developmental variation. p21Cip1 expression followed a
pattern that was inversely related to hepatocyte proliferation,
with the highest expression at term. In contrast, p27Kip1 was
expressed at nearly constant levels. Like p21Cip1, p57Kip2 ex-
pression peaked at term. However, no increase in p57Kip2 ex-
pression was seen in the adult.
Given the absence of a previously assigned role for p15Ink4b
and p57Kip2, additional experiments were performed in which
RNA preparations from multiple developmental time points
were analyzed by semi-quantitative RT-PCR (Fig. 2). p15Ink4b
expression increased during and beyond the ¢rst postnatal
week to levels that were highest in adult animals. In contrast,
expression of p57Kip2 was highest in near-term (E20) and term
(E21) animals with a marked decrease by 24 h after birth.
Further detailed studies of the remaining CKIs (not shown)
showed a modest perinatal rise in p21Cip1 expression, while
p27Kip1 and p18Ink4c expression levels remained constant
across all developmental ages studied (E17, E19, E20, E21,
P1, P2, P3, P4, P7, P14, P21, P28, adult). The expression of
p19Ink4d fell over the ¢rst 4 postnatal days, achieving levels
nearly as low as those seen in adult liver by the end of the ¢rst
postnatal week.
Table 1
PCR primer sequences and conditions for ampli¢cation of rat CKIs
Forward primer Reverse primer TA (‡C) No. of cycles Product size
(bp)
p21Cip1 5P-AGCAAAGTATGCCGTCGTCT-3P 5P-GAGTGCAAGACAGCGACAAG-3P 56 24 318
p27Kip1 5P-TAACCCGGGACTTGGAGAAG-3P 5P-CATTTTCTTCTGTTCTGTTGGC-3P 56 28 401
p57Kip2 5P-AGGAGCAGGACGAGAATCAA-3P 5P-TCTGGCCGTTAGCCTCTAAA-3P 56 26 267
p15Ink4b 5P-GGCTCAGAGACGAGCCCTGTA-3P 5P-AGATAGGGCTGGGGAGAAAA-3P 55 30 524
p16Ink4a 5P-GCAGATAGACTAGCCAGGGC-3P 5P-TAGGAGAGCAGGAGAGCTGC-3P 54 * 160
p18Ink4c 5P-GACCCTAAAGAATGGCCGAG-3P 5P-GGTGTCCCCCTTATGGTTC-3P 56 26 430
p19Ink4d 5P-CTTCTTCACCGGGAGCTG-3P 5P-CACCAAAAGGGGTGAGAAAA-3P 56 27 611
The number of cycles is that ¢gure for which semi-quantitation was optimal, except for p16Ink4a ampli¢cation (*), which was set at 35 cycles to
maximize product synthesis. TA, annealing temperature.
Fig. 1. CKI expression in late gestation fetal and adult liver. Tripli-
cate total liver RNA samples from E19 fetal rats, E21 fetal rats and
adult rats were used for semi-quantitative RT-PCR analysis of rela-
tive CKI mRNA content. Parallel L-actin analyses were carried out
in separate PCR reactions. Following gel electrophoresis, product
content was quanti¢ed by densitometry of the ethidium bromide-
stained bands. Results are presented as the mean plus 1 S.D. for
each group of triplicate analyses.
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To test the hypothesis that CKI expression maintains the
adult hepatocytes in a quiescent state, we studied livers from
adult animals that underwent two-thirds partial hepatectomy.
We hypothesized a decline in CKI expression following partial
hepatectomy. Time points of 6, 24, 48 and 72 h were chosen
to capture the phases of cell cycle entry and exit [8]. Results
(not shown) demonstrated that p21Cip1 was the ¢rst CKI to be
expressed following partial hepatectomy, being induced by 6 h
relative to the level seen in sham hepatectomy controls. By
24 h, partial hepatectomy induced an increase in the expres-
sion of all of the CKIs except p27Kip1, which was unchanged,
and p57Kip2, which could not be detected in any of the sam-
ples. The expression of all CKIs except p18Ink4c returned to
baseline by 72 h. Of note, in no case did partial hepatectomy
produce a decrease in CKI expression.
Northern analysis using a sub-cloned rat p57Kip2 PCR
product revealed a 4.5 kb signal (Fig. 3A) that con¢rmed
the results obtained using semi-quantitative RT-PCR results.
Western immunoblotting of whole liver extracts (Fig. 3B)
showed that p57Kip2 protein levels during the perinatal period
paralleled RNA expression. Immunoreactive p57Kip2 was not
detected following partial hepatectomy, consistent with the
RT-PCR results (not shown). We next employed immunohis-
tochemistry to obtain further con¢rmation of a hepatocyte
growth regulatory role for p57Kip2 (Fig. 3C). This method
allows con¢rmation that CKI expression is present in hepato-
cytes and not restricted to non-parenchymal liver cells or the
hematopoietic element in fetal liver. p57Kip2 staining was
prominent in the hepatocellular compartment and demon-
Fig. 2. p15Ink4b (upper panel) and p57Kip2 (lower panel) expression
during perinatal and postnatal liver development. Total liver RNA
preparations from fetal, newborn and maturing rats were analyzed
for CKI expression (solid bars) and L-actin expression (open bars)
using RT-PCR. E, embryonic day; P, postnatal day; Ad, adult. The
results of these representative experiments were con¢rmed in several
additional analyses.
Fig. 3. Analysis of p57Kip2 mRNA and protein content during liver development. A: Total RNA was obtained from animals sacri¢ced at the
developmental ages shown (P, postnatal day; P.25 represents 6 h after birth). The upper portion of the panel shows the autoradiogram ob-
tained by Northern blot, while the lower portion shows a photograph of the ethidium bromide-stained gel prior to transfer. B: Protein samples
were prepared from livers harvested at the developmental ages shown. The P.25 and P.75 samples were obtained 6 and 18 h after birth, respec-
tively. Numbers to the left of the resulting Western blot represent the position of molecular weight markers, while the position of p57Kip2 is
shown to the right of the autoradiogram. C: Tissue samples from rats ranging in age from E17 to adult were analyzed for p57Kip2 using immu-
nohistochemistry. Results for E19, E21 and P1 are shown. The ¢ndings represented by these three photomicrographs were con¢rmed in several
independent experiments.
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strated a nuclear distribution pattern. In agreement with the
RNA expression and Western immunoblotting results, levels
were higher in term (E21) than in pre-term (E19) liver. The
staining was nearly gone by the end of the ¢rst postnatal
day.
We further characterized a possible growth regulatory role
for p15Ink4b by studying its protein expression pattern. North-
ern analysis for p15Ink4b resulted in multiple transcripts that
were also identi¢ed using a mouse p16Ink4a probe. This lack of
speci¢city prevented us from con¢rming the RNA expression
pattern obtained using RT-PCR. In addition, p15Ink4b was not
detectable from whole liver samples by Western analysis or by
immunoprecipitation. However, it was readily detected in fetal
liver sections by immunohistochemistry (Fig. 4). Results
showed nuclear staining of p15Ink4b that was prominent at
E19 but markedly decreased by E21. This was followed by a
gradual increase in staining after birth. However, postnatal
staining was not con¢ned to the nucleus. In fact, adult liver
showed intense, di¡use staining for p15Ink4b. By 6 h after
partial hepatectomy, there was clearing of p15Ink4b from nu-
clei. By 24 h, there were patchy areas showing more extreme
loss of p15Ink4b staining. This persisted to 48 h. By 72 h (not
shown), staining was again intense and di¡use, similar to that
seen in unoperated adult animals.
While the role of CKIs has been intensely investigated in a
number of model systems, there previously has not been a
systematic examination of the pattern of CKI expression dur-
ing liver development. Our results indicate that two CKIs not
previously assigned a role in liver growth regulation, p15Ink4b
and p57Kip2, may be physiological regulators of the hepato-
cyte cell cycle.
p57Kip2 has not been previously identi¢ed as relevant to
liver biology. Prior studies did not show hepatic expression
[9,10], perhaps owing to the brief developmental window dur-
ing which it is induced in liver. Transfection of p57Kip2 into
osteosarcoma cells induces G1 arrest [10], and it can inhibit
the kinase activities of cyclin D- and cyclin E-associated
CDKs. Recent data indicate a broad physiological role for
p57Kip2. It appears to contribute to the terminal di¡erentia-
tion of several cell types, including lens ¢ber cells [11], myo-
blasts [12] and osteoblasts [13]. p57Kip2 knockout mice display
severe developmental defects and die immediately after birth
due to dyspnea from severe cleft palate, abdominal muscle
defects, and skeletal abnormalities [14]. No changes in liver
anatomy or histology were noted in the p57Kip2 nullizygous
animals. Based on mapping of the p57Kip2 gene to the Beck-
with^Wiedemann locus, p57Kip2 has been assigned a role in
the development of Wilms’ tumors and lung carcinomas in
Fig. 4. Immunohistochemistry for p15Ink4b. Tissue samples from rats ranging in age from E17 to adult were analyzed for p15Ink4b using immu-
nohistochemistry. Results for E19, E21 and adult rats are shown, as are representative sections of regenerating liver obtained 6, 24 and 48 h
after partial hepatectomy. These ¢ndings were con¢rmed in several independent experiments.
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these patients [15,16]. Thus, a potential role in hepatocyte
proliferation raises the possibility that p57Kip2 is involved in
the process of hepatic carcinogenesis.
Data regarding the role of p15Ink4b in development are lim-
ited. Quelle et al. [17], in cloning the murine p15Ink4b gene,
found that it was ubiquitously expressed in postnatal tissues.
Our data demonstrate, through both mRNA and protein
studies, a novel expression pattern for hepatic p15Ink4b and
suggest a putative role for p15Ink4b in the maintenance of
the quiescent state in adult rat hepatocytes. This is consistent
with the notion that, in the rat, adult hepatocytes are growth-
arrested and ‘primed’ for proliferation following injury [18].
The functional signi¢cance of the high level of expression in
adult liver is further supported by the ¢nding that partial
hepatectomy is associated with a rapid loss of nuclear
p15Ink4b. In addition, Santoni-Rugiu et al. [19] have shown
that c-myc-induced hepatocarcinogenesis in transforming
growth factor (TGF)-K transgenic mice is associated with dis-
rupted TGF-L induction of p15Ink4b. Finally, p15Ink4b has
been shown in one study to be deleted in nearly a quarter
of cases of hepatocellular carcinoma [20].
In summary, the developmental pattern of expression of
p15Ink4b and p57Kip2 indicates a role in hepatocyte biology.
The two CKIs may be involved in the induction of hepatocyte
growth arrest at two distinct points during liver development,
the perinatal period and the postnatal transition to a quies-
cent adult hepatocyte phenotype. This apparent involvement
in the physiological control of hepatocyte proliferation raises
the possibility of involvement of p15Ink4b and p57Kip2 in dis-
orders associated with pathophysiological hepatocyte prolifer-
ation.
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